Amgen Inc shows prevailing Real Value of $201.11 per share. The current price of the firm is $186.64. At this time the firm appears to be under valued. Macroaxis approximates value of Amgen Inc from analyzing the firm fundamentals such as Profit Margin of
35.46% and Return On Equity of 26.43% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point assets prices and their ongoing real values will blend.
Valuation Drivers Correlation
|Investment Horizon||30 Days Login to change|
Amgen Inc is rated second in five year return category among related companies. It is rated below average in price to earning category among related companies reporting about 8.80 of Price to Earning per Five Year Return.
Amgen is not too risky asset. Calculation of real value of Amgen Inc is based on 1 month time horizon. Increasing Amgen Inc time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.